Who invested in Oligomerix?
Oligomerix's investors include National Institutes of Health, Wheatley MedTech Partners, Durand Venture Associates and Wheatley New York Partners.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$6.5Mraised across 4 rounds since 2012, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $400K sold, first sale Apr 2015
Reported by manufacturing.pharmaceutical-business-review.com
Reported by pehub.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Oligomerix's investors include National Institutes of Health, Wheatley MedTech Partners, Durand Venture Associates and Wheatley New York Partners.
Oligomerix has raised $6.5M across 4 rounds since 2012. One round did not disclose an amount, so the total is a floor.
Oligomerix's most recent round was a Venture in Apr 2015.
Oligomerix's largest round on record is $2.8M (Series B), in May 2013.
Oligomerix's first round on record, in Apr 2012, was backed by Wheatley MedTech Partners, Durand Venture Associates and Wheatley New York Partners.
Oligomerix's latest named round is a Venture, in Apr 2015.
Oligomerix is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.